Duravest is a holding company that initiates investments in medical technology. Duravest researches ideas in their preclinical stages and moves these to commercialization through partnerships. The company has a majority investment in Estracure, which is developing coronary stents that potentially prevent the progression of coronary lesions.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.